Mediator lipidomics in acute inflammation and resolution

Journal of Biochemistry

Volumn 152, Issue 4, 2012, Pages 313-319

  Arita, Makoto ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

eosinophil; lipid mediator; metabolomics; n 3 PUFA; resolution of inflammation

Indexed keywords

ARACHIDONIC ACID; CD59 ANTIGEN; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; EPOXYICOSATRIENOIC ACID; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE B4; LIPOXIN; LIPOXYGENASE; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RETINOID X RECEPTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; BIOLOGICAL MONITORING; BIOTRANSFORMATION; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; COLITIS; DIET SUPPLEMENTATION; EOSINOPHIL; FATTY ACID ANALYSIS; HYDROLYSIS; IMMUNE RESPONSE; INFLAMMATION; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; METABOLIC SYNDROME X; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; STOMACH MUCOSA;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EOSINOPHILS; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; MOLECULAR STRUCTURE; TANDEM MASS SPECTROMETRY;

EID: 84866918835     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvs092     Document Type: Review

References (42)

1. Nathan, C. and Ding, A. (2010) Nonresolving inflammation. Cell 140, 871-882
2. Serhan, C.N., Brain, S.D., Buckley, CD., Gilroy, D.W., Haslett, C, O'Neill, L.A.J., Perretti, M., Rossi, A.G., and Wallace, J.L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332
3. Stables, M.J. and Gilroy, D.W. (2011) Old and new generation of lipid mediators in acute inflammation and resolution. Prog. Lipid Res. 50, 35-51
4. Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., and Yamamoto, K. (2011) Recent progress in phospholipase A2 research: from cells to animals to humans. Prog. Lipid Res. 50, 152-192
5. Murakai, M., Taketomi, Y., Sato, H., and Yamamoto, K. (2011) Secreted phospholipase A2 revisited. J. Biochem. 150, 233-255
6. Woodward, D.F., Jones, R.L., and Narumiya, S. (2011) International union of basic and clinical pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol. Rev. 63, 471-538
7. Smith, W.L., DeWitt, D.L., and Garavito, R.M. (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182
8. Murphy, R.C. and Gijon, M.A. (2007) Biosynthesis and metabolism of leukotrienes. Biochem. J. 405, 379-395
9. Kuhn, H. and O'Donnell, V.B. (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334-356
10. Peters-Golden, M. and Henderson, W.R. (2007) Leukotrienes. N. Engl. J. Med. 357, 1841-1854
11. Serhan, C.N. (2005) Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot. essent. Fatty Acids 73, 141-162
12. Kroetz, D.L. and Zeldin, D.C. (2002) Cytochrome P450 pathways of arachidonic acid metabolism. Curr. Opin. Lipidol. 13, 273-283
13. Funk, CD. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875
14. Simopoulos, A.P. (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr 21, 495-505
15. Kang, J.X. (2007) Fat-1 transgenic mice: a new model for omega-3 research. Prostaglandins Leukot. Eessent. Fatty Acids 77, 263-267
16. Schmitz, G and Ecker, J. (2008) The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 47, 147-155
17. Bannenberg, G and Serhan, C.N. (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim. Biophys. Acta. 1801, 1260-1273
18. Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N, and Gronert, K. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cycloox-ygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204
19. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A., and Serhan, C.N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722
20. Tjonahen, E., Oh, S.F., Siegelman, J., Elangovan, S., Percarpio, K.B., Hong, S., Arita, M., and Serhan, C.N. (2006) Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem. Biol. 13, 1193-1202
21. Oh, S.F., Pillai, P.S., Recchiuti, A., Yang, R., and Serhan, C.N. (2011) Pro-resolving actions and stereoselective biosynthesis of 18 S E-series resolvins in human leukocytes and murine inflammation. J. Clin. Invest. 121, 569-581
22. Serhan, C.N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S.P., and Petasis, N.A. (2006) Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosa-trienes. J. Immunol. 176, 1848-1859
23. Serhan, C.N., Yang, R., Martinod, K., Kasuga, K., Pillai, P.S., Porter, T.F., Oh, S.F., and Spite, M. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 15-23
24. Sun, Y.P., Oh, S.F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S.P., Petasis, N.A., and Serhan, C.N. (2007) Resolvin D1 and its aspirin-triggered 17 R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 9323-9334
25. Spite, M., Norling, L.V., Summers, L., Yang, R., Cooper, D., Petasis, N.A., Flower, R.J., Perretti, M., and Serhan, C.N. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291
26. Schwab, J.M., Chiang, N, Arita, M., and Serhan, C.N. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874
27. Chiang, N, Fredman, G., Backhed, F., Oh, S.F., Vickey, T., Schmidt, B.A., and Serhan, C.N. (2012) Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524-528
28. Serhan, C.N., Krishnamoorthy, S., Recchiuti, A., and Chiang, N. (2011) Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr. Top. Med. Chem. 11, 629-647
29. Krishnamoorthy, S., Recchiuti, A., Chiang, N, Yacoubian, S., Lee, C.H., Yang, R., Petasis, N.A., and Serhan, C.N. (2010) Resolvin D1 binds human phagocytes with evidence for pro-resolving receptors. Proc. Natl. Acad. Sci. USA 107, 1660-1665
30. Bang, S., Yoo, S., Oh, U., and Hwang, S. (2010) Endogenous lipid-derived ligands for sensory TRP ion channels and their pain modulation. Arch. Pharm. Res. 33, 1509-1520
31. Ji, R., Xu, Z., Strichartz, G, and Serhan, C.N. (2011) Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 34, 599-609
32. Cotran, R.S., Kumar, V., and Collins, T. (1999) Robbins Pathologic Basis of Disease., W.B. Saunders, Philadelphia
33. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K, and Serhan, C.N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612-619
34. Bannenberg, GL., Chiang, N, Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K.H., Hong, S., and Serhan, C.N. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355
35. Blaho, V.A., Buczynski, M.W., Brown, C.R., and Dennis, E.A. (2009) Lipidomic analysis of dynamic eico-sanoid responses during the induction and resolution of lyme arthritis. J. Biol. Chem. 284, 21599-21612
36. Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., Arita, M., and Arai, H. (2011) Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J. 25, 561-568
37. Isobe, Y., Arita, M., Matsueda, S., Iwamoto, R., Fujihara, T., Nakanishi, H., Taguchi, R., Masuda, K, Sasaki, K, Urabe, D., Inoue, M., and Arai, H. (2012) Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17, 18-dihydrox-yeicosapentaenoic acid. J. Biol. Chem. 287, 10525-10534
38. Rothenberg, M.E. and Hogan, S.P. (2006) The eosinophil. Annu. Rev. Immunol. 24, 147-174
39. Gronert, K, Maheshwari, N, Khan, N, Hassan, I.R., Dunn, M., and Schwartzman, M.L. (2005) A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267-15278
40. Merched, A.J., Ko, K, Gotlinger, K.H., Serhan, C.N., and Chan, L. (2008) Atherosclerosis. Evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595-3606
41. Kronke, G, Katzenbeisser, J., Uderhardt, S., Zaiss, M.M., Scholtysek, C, Schabbauer, G, Zarbock, A., Koenders, M.I., Axmann, R., Zwerina, J., Baenckler, H.W., van den Berg, W., Voll, R.E., Kuhn, H., Joosten, L.A.B., and Schett, G (2009) 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J. Immunol. 183, 3383-3389
42. Uderhardt, S., Herrmann, M., Oskolkova, O.V., Aschermann, S., Bicker, W., Ipseiz, N, Sarter, K, Frey, B., Rothe, T., Voll, R., Nimmerjahn, F., Bochkov, V.N., Schett, G, and Kronke, G (2012) 12/15-lipoxygenase orchestrates the clearance of apop-totic cells and maintains immunologic tolerance. Immunity 36, 1-13